Acquired resistance breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Axilla Neoplastic Stem Cells Nipples Lymph Nodes Cell Line Epithelial Cells Neoplastic Cells, Circulating Mammary Glands, Animal

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases38

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Carcinoma Ovarian Neoplasms Neoplasms, Hormone-Dependent Lymphatic Metastasis Neoplasm Recurrence, Local Disease Resistance Lung Neoplasms Neoplasms Disease Progression Fibrocystic Breast Disease Prostatic Neoplasms Colonic Neoplasms Cell Transformation, Neoplastic Bone Neoplasms Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Adenocarcinoma Neoplasms, Second Primary Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Pancreatic Neoplasms Fibroadenoma Neovascularization, Pathologic Neoplastic Cells, Circulating Uterine Cervical Neoplasms Neoplasms, Basal Cell Colorectal Neoplasms

Chemicals and Drugs62

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Epidermal Growth Factor Receptors, Estrogen Tamoxifen Receptors, Progesterone Antineoplastic Agents Tumor Markers, Biological Antineoplastic Agents, Hormonal Neoplasm Proteins Estrogen Receptor alpha RNA, Messenger Estrogens BRCA2 Protein Estrogen Antagonists BRCA1 Protein Aromatase Inhibitors RNA, Small Interfering DNA, Neoplasm Antibodies, Monoclonal, Humanized Estradiol Fluorouracil Anti-Bacterial Agents Estrogen Receptor Modulators Antibodies, Monoclonal Nitriles Cyclophosphamide Tumor Suppressor Protein p53 Selective Estrogen Receptor Modulators Epirubicin Paclitaxel Proto-Oncogene Proteins c-akt Oncogene Proteins v-erbB Quinazolines Tumor Suppressor Proteins Transcription Factors RNA, Neoplasm Antibiotics, Antineoplastic Antigens, Neoplasm Ki-67 Antigen P-Glycoprotein Triazoles DNA-Binding Proteins Doxorubicin Cancer Vaccines Proto-Oncogene Proteins DNA Primers Antigens, CD24 Anticarcinogenic Agents Protein Kinase Inhibitors MicroRNAs Phosphatidylinositol 3-Kinases Mucin-1 Anthracyclines Enzyme Inhibitors Cisplatin Protein-Serine-Threonine Kinases Antineoplastic Agents, Phytogenic ATP-Binding Cassette Transporters

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Mammography Prognosis Risk Factors Neoplasm Staging Early Detection of Cancer Mastectomy Chemotherapy, Adjuvant Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Mammary Neoplasms, Experimental Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Survival Analysis Immunohistochemistry Disease-Free Survival Breast Self-Examination Follow-Up Studies Risk Prospective Studies Survival Rate Blotting, Western Retrospective Studies Risk Assessment Treatment Outcome Xenograft Model Antitumor Assays Odds Ratio Incidence Mastectomy, Segmental Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Cohort Studies Multivariate Analysis Sensitivity and Specificity Neoplasm Transplantation Transplantation, Heterologous Transfection Registries Ultrasonography, Mammary Predictive Value of Tests Microbial Sensitivity Tests Tumor Burden Tissue Array Analysis Kaplan-Meier Estimate Logistic Models Questionnaires SEER Program Reproducibility of Results Combined Modality Therapy Drug Screening Assays, Antitumor Breast Implants Models, Biological Immunoenzyme Techniques Neoplasm Grading Molecular Targeted Therapy Clinical Trials as Topic Mass Screening Radiotherapy, Adjuvant Confidence Intervals Mammaplasty Gene Knockdown Techniques Neoadjuvant Therapy Drug Administration Schedule In Situ Hybridization, Fluorescence Genetic Testing Proportional Hazards Models DNA Mutational Analysis Biopsy Radiotherapy Biopsy, Needle Sentinel Lymph Node Biopsy Estrogen Replacement Therapy Lymph Node Excision

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes63

Genes, erbB Drug Resistance, Neoplasm Drug Resistance Gene Expression Regulation, Neoplastic Drug Resistance, Microbial Drug Resistance, Bacterial Mutation Genes, BRCA1 Drug Resistance, Multiple Postmenopause Cell Proliferation Genetic Predisposition to Disease Signal Transduction Genes, erbB-2 Breast Feeding Premenopause Risk Apoptosis Disease Resistance Menopause Time Factors Genotype Genes, BRCA2 Vascular Resistance Odds Ratio Drug Resistance, Viral Drug Resistance, Multiple, Bacterial Cell Division Phenotype Down-Regulation Cell Movement Sensitivity and Specificity Base Sequence Transfection Gene Amplification Dose-Response Relationship, Drug Phosphorylation Cell Survival Polymorphism, Genetic Promoter Regions, Genetic RNA Interference Up-Regulation Cell Growth Processes Gene Expression Germ-Line Mutation Cell Cycle DNA Methylation Gene Silencing Alleles Drug Synergism Parity Amino Acid Sequence Tetracycline Resistance Transcription, Genetic Genes, Neoplasm Epithelial-Mesenchymal Transition Genes, Tumor Suppressor Diet Genes, p53 Plant Diseases Heterozygote Penicillin Resistance Polymorphism, Single Nucleotide

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Molecular Sequence Data Incidence Base Sequence Registries Questionnaires SEER Program Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Case-Control Studies Survival Analysis Disease-Free Survival Follow-Up Studies Risk Prospective Studies Survival Rate Retrospective Studies Age Factors Risk Assessment Treatment Outcome Odds Ratio Incidence Cohort Studies Multivariate Analysis Sensitivity and Specificity Registries Predictive Value of Tests Kaplan-Meier Estimate Logistic Models Questionnaires SEER Program Reproducibility of Results Clinical Trials as Topic Mass Screening Confidence Intervals Parity Genetic Testing Proportional Hazards Models

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Breast Breast Neoplasms Carcinoma, Ductal, Breast Epidermal Growth Factor Receptors, Estrogen Cell Line, Tumor Genes, erbB Drug Resistance, Neoplasm Breast Diseases Drug Resistance Gene Expression Regulation, Neoplastic Tamoxifen Receptors, Progesterone Mammography Neoplasm Metastasis Neoplasm Invasiveness Drug Resistance, Microbial Prognosis Drug Resistance, Bacterial Antineoplastic Agents Tumor Markers, Biological Antineoplastic Agents, Hormonal Breast Neoplasms, Male Neoplasm Proteins Risk Factors Neoplasm Staging Early Detection of Cancer Mastectomy Tumor Cells, Cultured Mutation Genes, BRCA1 Drug Resistance, Multiple Postmenopause Mice, Nude Chemotherapy, Adjuvant Carcinoma, Lobular MCF-7 Cells Cell Proliferation Genetic Predisposition to Disease Signal Transduction Genes, erbB-2 Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Survival Analysis Estrogen Receptor alpha Immunohistochemistry Carcinoma RNA, Messenger Estrogens Breast Feeding Premenopause Ovarian Neoplasms Neoplasms, Hormone-Dependent Disease-Free Survival Breast Self-Examination Follow-Up Studies Risk Lymphatic Metastasis Neoplasm Recurrence, Local Apoptosis Disease Resistance Prospective Studies Lung Neoplasms Neoplasms Survival Rate Menopause BRCA2 Protein Time Factors Blotting, Western Estrogen Antagonists BRCA1 Protein Genotype Genes, BRCA2 Retrospective Studies Disease Progression Aromatase Inhibitors Age Factors Risk Assessment Treatment Outcome Vascular Resistance Fibrocystic Breast Disease Molecular Sequence Data Mammary Glands, Human Xenograft Model Antitumor Assays RNA, Small Interfering Survivors Prostatic Neoplasms Odds Ratio Incidence Mastectomy, Segmental Axilla

No FAQ available that match "acquired resistance breast cancers receptor erbb 2"